Keywords: |
signal transduction; child; clinical trial; nonhuman; note; letter; mouse; animal; mouse mutant; animals; mice; neurofibromatosis; neurofibromatosis 1; drug effect; disease model; cognition; neurofibromin; ras protein; cognitive defect; cholesterol; behavior disorder; genetic disorder; memory; disease models, animal; hydroxymethylglutaryl coenzyme a reductase inhibitor; simvastatin; hydroxymethylglutaryl-coa reductase inhibitors; mevinolin; learning disorder; cholesterol metabolism; grape juice; mice, neurologic mutants
|